Proinflammatory cytokine and nitric oxide production by human macrophages stimulated with Trichomonas vaginalis

Korean Journal of Parasitology

Volumn 47, Issue 3, 2009, Pages 205-212

  Han, Ik Hwan ^a   Goo, Sung Young ^b   Park, Soon Jung ^b   Hwang, Se Jin ^a   Kim, Yong Seok ^a   Yang, Michael Sungwoo ^c   Ahn, Myoung Hee ^a   Ryu, Jae Sook ^a  

^a Hanyang University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Indianhead International School   (South Korea)

Author keywords

Human monocyte derived macrophage; INOS; NF B; Nitric oxide; Proinflammatory cytokine; Trichomonas vaginalis

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; N(G) METHYLARGININE; NITRIC OXIDE; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRICHOMONAS VAGINALIS;

ANIMALS; CELLS, CULTURED; CYTOKINES; HUMANS; MACROPHAGES; NITRIC OXIDE; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS;

TRICHOMONADIDA; TRICHOMONAS VAGINALIS;

EID: 70349217115     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2009.47.3.205     Document Type: Article

References (29)

1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva, Switzerland. WHO. 2001.
2. Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev 2009; 22: 37-45.
3. Kiviat NB, Paavonen JA, Brockway J, Critchlow CW, Brunham RC, Stevens CE, Stamm WE, Kuo CC, DeRouen T, Holmes KK. Cytological manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA 1985; 253: 989-996.
4. Levine WC, Pope V, Bhoomkar A, Tambe P, Lewis JS, Zaidi AA, Farshy CE, Mitchell S, Talkington DF. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177: 167-174.
5. Sardana S, Sodhani P, Agarwal SS, Sehgal A, Roy M, Singh V, Bhatnagar P, Murthy NS. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Acta Cytol 1994; 38: 693-697.
6. Landolfo S, Martinotti MG, Martinetto P, Forni G. Natural cellmediated cytotoxicity against Trichomonas vaginalis in the mouse. I. Tissue, strain, age distribution, and some characteristics of the effector cells. J Immunol 1980; 124: 508-514.
7. Ryu JS, Ahn MH, Min DY. Cytotoxicity of resident and lymphokine-activated mouse peritoneal macrophage against Trichomonas vagianalis. Korean J Parasitol 1990; 28: 85-89.
8. Yoon K, Ryu JS, Min DY. Cytotoxicity of lymphokine activated peritoneal macrophages against Trichomonas vaginalis. Korean J Parasitol 1991; 29: 381-388.
9. Park GC, Ryu JS, Min DY. The role of nitric oxide as an effector of macrophage-mediated cytotoxicity against Trichomonas vaginalis. Korean J Parasitol 1997; 35: 189-195.
10. Ahn MH, Song HO, Ryu JS. Trichomonas vaginalis-induced neutrophil apoptosis causes anti-inflammatory cytokine production by human monocyte-derived macrophages. Parasite Immunol 2008; 30: 410-416.
11. Lee EJ, Heo YM, Choi JH, Song HO, Ryu JS, Ahn MH. Suppressed production of pro-inflammatory cytokines by LPS-activated macrophages after treatment with Toxoplasma gondii lysate. Korean J Parasitol 2008; 46: 145-151.
12. Kim YS, Song HO, Choi IH, Park SJ, Ryu JS. Hydrogenosomal activity of Trichomonas vaginalis cultivated under different iron conditions. Korean J Parasitol 2006; 44: 373-378.
13. Magez S, Radwanska M, Drennan M, Fick L, Baral TN, Allie N, Jacobs M, Nedospasov S, Brombacher F, Ryffel B, De Baetselier P. Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing. J Infect Dis 2007; 196: 954-962.
14. Taubert A, Behrendt JH, Suhwold A, Zahner H, Hermosilla C. Monocyte-and macrophage-mediated immune reactions against Eimeria bovis. Vet Parasitol 2009. doi:10.1016/j.vetpar.2009.06. 003.
15. Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SMB, Nascimento ET, Britigan BE, Wilson ME. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunology 2001; 167: 893-901.
16. Dasgupta B, Roychoudhury K, Ganguly S, Akbar MA, Das P, Roy S. Infection of human mononuclear phagocytes and macrophagelike THP1 cells with Leishmania donovani results in modulation of expression of a subset of chemokines and a chemokine receptor. Scand J Immunol 2003; 57: 366-374.
17. Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998; 25: 434-456.
18. Rogers JA, Fuseler JW. Regulation of NF-κB activation and nuclear translocation by exogenous nitric oxide (NO) donors in TNF-α activated vascular endothelial cells. Nitric Oxide 2007; 16: 379-391.
19. Thomassen MJ, Kavuru MS. Human alveolar macrophages and monocytes as a source and target for nitric oxide. Int Immunopharmacol 2001; 1: 1479-1490.
20. Jung WK, Choi IH, Lee DY, Yea SS, Choi YH, Kim MM, Park SG, Seo SK, Lee SW, Lee CM, Park YM, Choi IW. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-κB pathways. Int J Biochem Cell Biol 2008; 40: 2572-2582.
21. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-4708.
22. Zhang Z, Kolls JK, Oliver P, Good D, Schwarzenberger PO, Joshi MS, Ponthier JL, Lancaster JRJr. Activation of tumor necrosis factor-α-converting enzyme-mediated ectodomain shedding by nitric oxide. J Biol Chem 2000; 275: 15839-15844.
23. Stevanin TM, Laver JR, Poole RK, Moir JWB, Read RC. Metabolism of nitric oxide by Neisseria meningitidis modifies release of NO-regulated cytokines and chemokines by human macrophages. Microbes Infect 2007; 9: 981-987.
24. Yan L, Wang S, Rafferty SP, Wesley RA, Danner RL. Endogenously produced nitric oxide increases tumor necrosis factor-α production in transfected human U937 cells. Blood 1997; 90: 1160-1167.
25. Huang FP, Niedbala W, Wei XQ, Xu D, Feng GJ, Robinson JH, Lam C, Liew FY. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol 1998; 28: 4062-4070.
26. Guo RF, Ward PA. Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radic Biol Med 2002; 33: 303-310.
27. Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka F, Maruyama Y, Matsushita I, Iwaoka Y, Saniabadi A. Correlation of serum soluble TNF-α receptors I and II levels with disease activity in patients with ulcerative colitis. Am J Gastroenterol 2004; 99: 1532-1538.
28. Ryu JS, Kang JH, Jung SY, Shin MH, Kim JM, Park H, Min DY. Production of Interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis. Infect Immun 2004; 72: 1326-1332.
29. Schröer JM. Chemoattractants as mediators of neutrophilic tissue recruitment. Clin Dermatol 2000; 18: 245-263.